Moody Aldrich Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
+1,285
| New | +$222K | 0.04% | 168 |
|
|
2024
Q4 | – | Sell |
-1,520
| Closed | -$227K | – | 202 |
|
|
2024
Q3 | $227K | Sell |
1,520
-3
| -0.2% | -$448 | 0.04% | 184 |
|
|
2024
Q2 | $208K | Hold |
1,523
| – | – | 0.04% | 191 |
|
|
2024
Q1 | $230K | Buy |
+1,523
| New | +$230K | 0.04% | 200 |
|
|
2020
Q3 | – | Sell |
-22,690
| Closed | -$3.36M | – | 157 |
|
|
2020
Q2 | $3.36M | Buy |
22,690
+8,987
| +66% | +$1.33M | 0.71% | 63 |
|
|
2020
Q1 | $1.54M | Sell |
13,703
-4,442
| -24% | -$500K | 0.47% | 79 |
|
|
2019
Q4 | $2.52M | Buy |
+18,145
| New | +$2.52M | 0.52% | 79 |
|